Experimental lymphoma combo trial halted early
Disease control
Terminated
This study tested a drug called selinexor combined with chemotherapy or another drug (tislelizumab) in 56 adults with relapsed or hard-to-treat T-cell or NK-cell lymphoma. The goal was to see if the combination was safe and could shrink tumors. The trial was stopped early, so res…
Phase: PHASE1, PHASE2 • Sponsor: Antengene Corporation • Aim: Disease control
Last updated May 11, 2026 20:54 UTC